Avadel Pharmaceuticals PLC
NASDAQ:AVDL
During the last 3 months Avadel Pharmaceuticals PLC insiders have not bought any shares, and have not sold any shares. The stock price has increased by 14% over this period (open performance analysis).
The last transaction was made on
Jan 21, 2025
by
Palczuk Linda
(Chief Scientific Officer)
, who
bought
39.6k USD
worth of AVDL shares.
During the last 3 months Avadel Pharmaceuticals PLC insiders have not bought any shares, and have not sold any shares. The stock price has increased by 14% over this period (open performance analysis).
The last transaction was made on
Jan 21, 2025
by
Palczuk Linda
(Chief Scientific Officer)
, who
bought
39.6k USD
worth of AVDL shares.
Avadel Pharmaceuticals PLC
Glance View
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. The company is headquartered in Dublin, Dublin and currently employs 66 full-time employees. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcolepsy patients. Its Micropump allows for the development of modified and/or controlled release solid, oral dosage formulations of drugs. Its LiquiTime technology allows for development of modified/controlled release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its Medusa technology allows for the development of extended-/modified-release injectable dosage formulations of drugs.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet